Project Grant HT94252410576
Award Date
9/30/24
Completion Date
9/29/27
Dollars Obligated
$768K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
College Station, TX 77843, USA
Similar Awards
The Department of the Army Medical Command awarded a $1.85 million Project Grant to Texas A&M University System Health Science Center to support research probing neuroinflammation in Gulf War illness via studies on Gulf War veteran-derived microglia. The grant was awarded on September 30, 2022 under the Military Medical Research and Development program (CFDA 12.420) and will run through September 29, 2025. As part of the award, $150,000 in sub-award funding was provided to Drexel...
The Defense Health Agency has awarded a $760,844.00 Project Grant to the Texas A&M University System Health Science Center to conduct research under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, awarded on September 15, 2023 with a completion date of September 14, 2026, will fund research titled "Targeting the MIF/CD74 Immune Axis to Treat GWI Astrocyte, Neuronal, and Cognitive Dysfunction." This research aims to investigate medical...
This $1,224,089 Department of Defense Project Grant awarded on September 30, 2023 to Texas A&M University System Health Science Center will fund a 3-year research project titled "CONTRIBUTION OF CELLULAR SENESCENCE AND BRAIN AGING TO COGNITIVE DYSFUNCTION IN GWI". The project will be conducted under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), which supports a broad range of biomedical research to transform healthcare for Service...
The Department of the Army Medical Command awarded a $564,698.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Texas A&M Engineering Experiment Station (Tees) to develop "Engineered Therapeutic Extracellular Vesicles to Resolve Pyridostigmine Bromide-Induced Enteric Neuroinflammation in Gulf War Illness." The grant, with a performance period from November 1, 2024 to October 31, 2027, will support advanced biomedical research...
This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $669,421.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on the long-term impact of deployment exposures on neuropathy of brainstem pathways, associated symptoms, and health measures in veterans with Gulf War Illness. The research will be performed over a two-year period from September 30, 2024 to...
The U.S. Defense Health Agency awarded a $817,027 Project Grant to The Roskamp Institute, Inc. in Sarasota, Florida under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, running from August 15, 2023 to August 14, 2026, will support the institute's research on an "amnion-derived multipotent cell secretome-medicated therapy for Gulf War Illness." The Roskamp Institute is a non-profit biotechnology research organization that has previously...
The U.S. Department of Defense, Defense Health Agency has awarded a $918,000 Project Grant to the Texas A&M University System Health Science Center to conduct research on "INNATE AND ADAPTIVE IMMUNE MECHANISMS OF CD74 IN POST-TRAUMATIC EPILEPSY". This 3-year grant, running from September 15, 2024 to September 14, 2027, is funded under the Military Medical Research and Development (CFDA 12.420) program. The project aims to investigate basic and translational research on the role...
The Defense Health Agency awarded Duke University a $759,627.49 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ACCELERATED AGING IN GULF WAR ILLNESS: PHENOTYPES, EPIGENETIC BIOMARKERS, AND ASSOCIATIONS WITH GULF WAR EXPOSURES." The project will run from August 1, 2023 to July 31, 2026. Duke University, a top-ranked global research institution, will be the prime awardee and perform the research through its Office of...
The Department of the Army Medical Command awarded a $909,291 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Texas A&M University System Health Science Center, Finance And Business Services Division for the project "INNATE AND ADAPTIVE IMMUNE MECHANISMS OF CD74 IN POST-TRAUMATIC EPILEPSY". The grant will fund research over a 3-year period from Sep 2024 to Sep 2027 to investigate the role of the CD74 protein in the development of...
The Department of the Army Medical Command awarded $745,304 to Texas A&M University Health Science Center under the Military Medical Research and Development program (CFDA 12.420) to support the project "Epigenetic Therapy for Post-Traumatic Epilepsy" from September 30, 2022 through September 29, 2025. The project aims to develop innovative medical solutions for traumatic brain injury through basic, applied, and advanced biomedical research investigating epigenetic approaches to...